A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Czechia- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Jihlavska 340/20, Bohunice, 625 00 Brno, Czechia
Fakultni Nemocnice Brno in Brno, Czechia specialises in clinical trials of conditions such as Plasma cell myeloma, Chronic lymphocytic leukaemia, Asthma, Plasma cell myeloma refractory, and other specialisations. This site conducts important research.
Clinical trials in cardiovascular diseases focus on major conditions such as acute myocardial infarction, acute coronary syndrome, atrial fibrillation, and chronic heart failure. This work is aimed at testing new ways to prevent complications, improve heart protection, and support better recovery after serious cardiac events.
These studies reflect a strong clinical focus on safer, more effective treatment strategies for patients with high-risk heart and blood vessel conditions.
The site is active in neoplasms and hemic and lymphatic diseases, with research spanning breast cancer, lung cancer, renal cell carcinoma, lymphoma, multiple myeloma, and myelodysplastic syndrome. These trials are generally designed to compare new treatment approaches with current standards and to improve disease control and survival.
This research supports ongoing efforts to improve outcomes for patients with difficult-to-treat blood cancers and solid tumors.
Research in respiratory tract diseases includes asthma, chronic obstructive pulmonary disease, and respiratory syncytial virus prevention. The trials aim to reduce exacerbations, lower dependence on existing medicines, and strengthen protection for vulnerable groups.
At the Internal Cardiology Clinic, these studies add to a broader portfolio that combines chronic disease management with prevention-focused care.
Several trials address immune system diseases and inflammatory disorders such as psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and psoriasis. The main goal is to evaluate therapies that may better control symptoms, reduce inflammation, and improve daily functioning.
This area shows an emphasis on long-term symptom relief and better disease control for patients with persistent inflammatory conditions.
Clinical activity also includes nervous system diseases, multiple sclerosis, myasthenia gravis, psychoses, and imaging-related diagnostic studies. These trials are designed to improve treatment options, better understand disease behavior, and refine diagnostic evaluation.
These studies highlight a balanced interest in both advanced treatment and better diagnostic tools for complex neurological and psychiatric conditions.
The trial portfolio also includes female urogenital diseases, virus diseases, and blood disorders such as haemophilia A, alongside conditions like endometriosis and uveitic macular edema. Research here often focuses on symptom relief, safety, and improved quality of life.
Across these diverse studies, Fakultni Nemocnice Brno supports clinical research aimed at practical improvements in diagnosis, prevention, and treatment.
Clinical trials currently enrolling participants at this site.
CzechiaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
CzechiaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
CzechiaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
CzechiaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
CzechiaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
CzechiaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
CzechiaA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
CzechiaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
CzechiaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
CzechiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
CzechiaStudy on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
CzechiaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.